Immune aging biomarkers for clinical trials
Nature Medicine · Consensus perspective
An expert consensus co-authored by Jamie Justice, Executive Director of XPRIZE Healthspan, and Edifice founder David Furman sets five criteria for immune aging biomarkers in clinical trials and names iAge® (or similar inflammaging scores) as a prespecified biomarker for the XPRIZE Healthspan competition.